| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4006262 | American Journal of Ophthalmology | 2006 | 7 Pages |
Abstract
Long-term topical CsA 2% therapy is safe and effective in children with phlyctenular keratoconjunctivitis associated with severe steroid-dependent corneal inflammation.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Serge MD, Eric MD, Damien MD, Minh-Hanh MD, Olivia MD, Thanh MD,